TriangleWhat a Phase 1 cancer trial actually is
The first time a new treatment is given to people. The study is built around safety and dose, not around proving the drug works.
This is not clinical evidence and not medical advice. It does not replace your care team. Discuss anything here with your clinician before you act on it. Product questions are on the FAQ.
When I first saw “Phase 1” on a listing I assumed it meant experimental in the Hollywood sense: last resort, unknown drug, fingers crossed. That is not what the phase number means.
A Phase 1 cancer trial is usually the first study of a new drug, cell therapy, or other intervention in people. The questions it is built to answer are: is this safe, what are the side effects, and how does the body handle it. It is not built to prove the treatment is better than standard care. Later phases ask that.
What they are trying to learn
Sponsors use Phase 1 to find a dose people can tolerate and to watch for unexpected harm. Some of these studies also look for early signs that the cancer is responding. That is a bonus observation, not the point of the design.
The public record of how a given study is designed sits on ClinicalTrials.gov. That listing is what our Phase 1 pages are built from.
See recruiting Phase 1 trials →
Sources
- FDA: The Drug Development Process — Step 3: Clinical ResearchPhase 1 studies are primarily about safety and dosing in people, not whether the treatment works better than standard care.
- ClinicalTrials.govClinicalTrials.gov is the public registry for how a given study is designed.